E3 Ligase Activity of BRCA1 is Not Essential for Mammalian Cell Viability or Homology-directed Repair of Double-strand DNA Breaks

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 2008 Dec 18

PMID 19088202

Citations 85

Authors

Latarsha J Reid

Reena Shakya

Ami P Modi

Maria Lokshin

Jiin-Tsuey Cheng

Maria Jasin

Richard Baer

Thomas Ludwig

Affiliations

Soon will be listed here.

Abstract

Hereditary cases of breast and ovarian cancer are often attributed to germ-line mutations of the BRCA1 tumor suppressor gene. Although BRCA1 is involved in diverse cellular processes, its role in the maintenance of genomic integrity may be a key component of its tumor suppression activity. The protein encoded by BRCA1 interacts in vivo with the related BARD1 protein to form a heterodimeric complex that acts as a ubiquitin E3 ligase. Because the enzymatic activity of the BRCA1/BARD1 heterodimer is conserved over a broad phylogenetic range, it is thought to be critical for the central functions of BRCA1. To test this hypothesis, we have generated isogenic clones of embryonic stem cells that do or do not express an enzymatically proficient Brca1 polypeptide. Surprisingly, cells lacking the ubiquitin ligase activity of BRCA1 are viable and do not accumulate spontaneous cytogenetic rearrangements. Gene targeting efficiencies are modestly reduced in these cells, and chromosomal rearrangements arise at elevated rates in response to genotoxic stress. Nonetheless, cells lacking Brca1 enzymatic activity are not hypersensitive to the DNA cross-linking agent mitomycin C. They also form Rad51 focus in response to ionizing radiation and repair chromosome breaks by homologous recombination at wild-type levels. These results indicate that key aspects of BRCA1 function in genome maintenance, including its role in homology-directed repair of double-strand DNA breaks, do not depend on the E3 ligase activity of BRCA1.

Citing Articles

BRCA1 and BRCA2: from cancer susceptibility to synthetic lethality.

Khalizieva A, Moser S, Bouwman P, Jonkers J Genes Dev. 2024; 39(1-2):86-108.

PMID: 39510841 PMC: 11789497. DOI: 10.1101/gad.352083.124.

E3 ligases: a ubiquitous link between DNA repair, DNA replication and human disease.

Chauhan A, Jhujh S, Stewart G Biochem J. 2024; 481(14):923-944.

PMID: 38985307 PMC: 11346458. DOI: 10.1042/BCJ20240124.

BRCA1/BARD1 ubiquitinates PCNA in unperturbed conditions to promote continuous DNA synthesis.

Salas-Lloret D, Garcia-Rodriguez N, Soto-Hidalgo E, Gonzalez-Vinceiro L, Espejo-Serrano C, Giebel L Nat Commun. 2024; 15(1):4292.

PMID: 38769345 PMC: 11106271. DOI: 10.1038/s41467-024-48427-6.

Brca1 Mouse Models: Functional Insights and Therapeutic Opportunities.

Yueh W, Glass D, Johnson N J Mol Biol. 2023; 436(1):168372.

PMID: 37979908 PMC: 10882579. DOI: 10.1016/j.jmb.2023.168372.

Crucial roles of the BRCA1-BARD1 E3 ubiquitin ligase activity in homology-directed DNA repair.

Wang M, Li W, Tomimatsu N, Yu C, Ji J, Alejo S Mol Cell. 2023; 83(20):3679-3691.e8.

PMID: 37797621 PMC: 10591799. DOI: 10.1016/j.molcel.2023.09.015.

References

Elledge S, Amon A . The BRCA1 suppressor hypothesis: an explanation for the tissue-specific tumor development in BRCA1 patients. Cancer Cell. 2002; 1(2):129-32. DOI: 10.1016/s1535-6108(02)00041-7. View

Nishikawa H, Ooka S, Sato K, Arima K, Okamoto J, Klevit R . Mass spectrometric and mutational analyses reveal Lys-6-linked polyubiquitin chains catalyzed by BRCA1-BARD1 ubiquitin ligase. J Biol Chem. 2003; 279(6):3916-24. DOI: 10.1074/jbc.M308540200. View

Snouwaert J, Gowen L, Latour A, Mohn A, Xiao A, Dibiase L . BRCA1 deficient embryonic stem cells display a decreased homologous recombination frequency and an increased frequency of non-homologous recombination that is corrected by expression of a brca1 transgene. Oncogene. 2000; 18(55):7900-7. DOI: 10.1038/sj.onc.1203334. View

Xu X, Weaver Z, Linke S, Li C, Gotay J, Wang X . Centrosome amplification and a defective G2-M cell cycle checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells. Mol Cell. 1999; 3(3):389-95. DOI: 10.1016/s1097-2765(00)80466-9. View

Nagaraju G, Scully R . Minding the gap: the underground functions of BRCA1 and BRCA2 at stalled replication forks. DNA Repair (Amst). 2007; 6(7):1018-31. PMC: 2989184. DOI: 10.1016/j.dnarep.2007.02.020. View

Wu L, Wang Z, Tsan J, Spillman M, Phung A, Xu X . Identification of a RING protein that can interact in vivo with the BRCA1 gene product. Nat Genet. 1996; 14(4):430-40. DOI: 10.1038/ng1296-430. View

Pierce A, Hu P, Han M, Ellis N, Jasin M . Ku DNA end-binding protein modulates homologous repair of double-strand breaks in mammalian cells. Genes Dev. 2001; 15(24):3237-42. PMC: 312854. DOI: 10.1101/gad.946401. View

Evers B, Jonkers J . Mouse models of BRCA1 and BRCA2 deficiency: past lessons, current understanding and future prospects. Oncogene. 2006; 25(43):5885-97. DOI: 10.1038/sj.onc.1209871. View

Hakem R, de la Pompa J, Sirard C, Mo R, Woo M, Hakem A . The tumor suppressor gene Brca1 is required for embryonic cellular proliferation in the mouse. Cell. 1996; 85(7):1009-23. DOI: 10.1016/s0092-8674(00)81302-1. View

10.

Ludwig T, CHAPMAN D, Papaioannou V, Efstratiadis A . Targeted mutations of breast cancer susceptibility gene homologs in mice: lethal phenotypes of Brca1, Brca2, Brca1/Brca2, Brca1/p53, and Brca2/p53 nullizygous embryos. Genes Dev. 1997; 11(10):1226-41. DOI: 10.1101/gad.11.10.1226. View

11.

Shakya R, Szabolcs M, McCarthy E, Ospina E, Basso K, Nandula S . The basal-like mammary carcinomas induced by Brca1 or Bard1 inactivation implicate the BRCA1/BARD1 heterodimer in tumor suppression. Proc Natl Acad Sci U S A. 2008; 105(19):7040-5. PMC: 2365565. DOI: 10.1073/pnas.0711032105. View

12.

Deng C . BRCA1: cell cycle checkpoint, genetic instability, DNA damage response and cancer evolution. Nucleic Acids Res. 2006; 34(5):1416-26. PMC: 1390683. DOI: 10.1093/nar/gkl010. View

13.

Bhattacharyya A, Ear U, Koller B, Weichselbaum R, Bishop D . The breast cancer susceptibility gene BRCA1 is required for subnuclear assembly of Rad51 and survival following treatment with the DNA cross-linking agent cisplatin. J Biol Chem. 2000; 275(31):23899-903. DOI: 10.1074/jbc.C000276200. View

14.

McCarthy E, Celebi J, Baer R, Ludwig T . Loss of Bard1, the heterodimeric partner of the Brca1 tumor suppressor, results in early embryonic lethality and chromosomal instability. Mol Cell Biol. 2003; 23(14):5056-63. PMC: 162231. DOI: 10.1128/MCB.23.14.5056-5063.2003. View

15.

Shen S, Weaver Z, Xu X, Li C, Weinstein M, Chen L . A targeted disruption of the murine Brca1 gene causes gamma-irradiation hypersensitivity and genetic instability. Oncogene. 1999; 17(24):3115-24. DOI: 10.1038/sj.onc.1202243. View

16.

Joukov V, Chen J, Fox E, Green J, Livingston D . Functional communication between endogenous BRCA1 and its partner, BARD1, during Xenopus laevis development. Proc Natl Acad Sci U S A. 2001; 98(21):12078-83. PMC: 59770. DOI: 10.1073/pnas.211427098. View

17.

Brzovic P, Keeffe J, Nishikawa H, Miyamoto K, Fox 3rd D, Fukuda M . Binding and recognition in the assembly of an active BRCA1/BARD1 ubiquitin-ligase complex. Proc Natl Acad Sci U S A. 2003; 100(10):5646-51. PMC: 156255. DOI: 10.1073/pnas.0836054100. View

18.

Christensen D, Brzovic P, Klevit R . E2-BRCA1 RING interactions dictate synthesis of mono- or specific polyubiquitin chain linkages. Nat Struct Mol Biol. 2007; 14(10):941-8. DOI: 10.1038/nsmb1295. View

19.

Lorick K, Jensen J, Fang S, Ong A, Hatakeyama S, Weissman A . RING fingers mediate ubiquitin-conjugating enzyme (E2)-dependent ubiquitination. Proc Natl Acad Sci U S A. 1999; 96(20):11364-9. PMC: 18039. DOI: 10.1073/pnas.96.20.11364. View

20.

Yang H, Li Q, Fan J, Holloman W, Pavletich N . The BRCA2 homologue Brh2 nucleates RAD51 filament formation at a dsDNA-ssDNA junction. Nature. 2005; 433(7026):653-7. DOI: 10.1038/nature03234. View